直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Slashes $10.5M Verdict, Citing Flaws in Infringement and Damages Rulings

October 29, 2024

Authored and Edited by A. Sasha Hoyt; Christopher B. Anderson; Sonja W. Sahlsten; Prince M. Ene, Pharm. D.

In Provisur Technologies, Inc. v. Weber, Inc., No. 2023-1438 (Fed. Cir. Oct. 2, 2024), the Federal Circuit issued a mixed ruling, affirming infringement findings for two of three patents and reversing decisions on willfulness and damages.

Provisur accused Weber of infringing claims of three patents related to high-speed mechanical food slicers. A jury found Weber willfully infringed all three patents and awarded over $10 million in damages. Weber moved for judgment as a matter of law and a new trial. The district court denied both motions.

On appeal, the Federal Circuit reversed the jury’s findings of infringement for one of the patents at issue,[1] finding Provisur failed to proffer substantial evidence of infringement. While some evidence suggested it was possible to reconfigure Weber’s accused products in an infringing manner, no evidence of record demonstrated Weber’s products were sold in an infringing configuration or that they could be reprogrammed by its customers to activate such a configuration.

Regarding willfulness, the Federal Circuit found that the district court improperly admitted expert testimony regarding Weber’s purported failure to seek a freedom to operate analysis or other legal services from a third party, in violation of 35 U.S.C. § 298. The remaining evidence, while admissible, failed to establish Weber’s specific intent to infringe as a matter of law.

Finally, the Federal Circuit found that the district court improperly permitted Provisur to use the “entire market value rule” for damages, rather than calculate a reasonable royalty based on apportionment between infringing and non-infringing features of Weber’s products. Weber’s systems included several non-infringing features—some of which Weber itself patented—and Provisur’s expert offered no evidence that Provisur’s patented features alone drove customer demand for Weber’s entire slicing systems or substantially created its value. The case was remanded for a new trial on damages.

Endnotes

[1] Weber conceded infringement of the remaining two patents during oral argument due to an intervening decision.

Tags

patent infringement, willful infringement, damages, reasonable royalty

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

Consumer Goods and Services

Food and Beverage

Related Offices

Washington, DC

Contacts

A. Sasha Hoyt
Associate
Washington, DC
+1 202 408 4230
Email
Christopher B. Anderson
Associate
Reston, VA
+1 571 203 2765
Email
Sonja W. Sahlsten
Partner
Washington, DC
+1 202 408 4329
Email
Prince M. Ene, Pharm. D.
Associate
Washington, DC
+1 202 408 4036
Email

Copyright © 2024 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP